501378-52-5 Usage
Uses
Used in Organic Synthesis:
2-(benzyloxy)isonicotinonitrile is used as a building block for the preparation of various pharmacologically active molecules. Its unique structure allows for the synthesis of a wide range of compounds with potential therapeutic applications.
Used in Drug Development:
BICN is used in the development and discovery of new drugs for the treatment of various diseases and conditions. Its versatility and reactivity make it a valuable tool in medicinal chemistry for designing and optimizing drug candidates.
Used in Antimicrobial Applications:
2-(benzyloxy)isonicotinonitrile has been studied for its potential antimicrobial properties. It may be used as an antimicrobial agent to combat bacterial infections, particularly those resistant to conventional antibiotics.
Used in Antifungal Applications:
BICN has also been investigated for its antifungal properties. It may be employed as an antifungal agent to treat fungal infections and control the growth of various fungi.
Used in Anticancer Applications:
2-(benzyloxy)isonicotonitrile has shown promise as a potential anticancer agent. It may be used in the development of new cancer therapies, targeting various types of cancer cells and exhibiting inhibitory effects on tumor growth and progression.
Check Digit Verification of cas no
The CAS Registry Mumber 501378-52-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,1,3,7 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 501378-52:
(8*5)+(7*0)+(6*1)+(5*3)+(4*7)+(3*8)+(2*5)+(1*2)=125
125 % 10 = 5
So 501378-52-5 is a valid CAS Registry Number.
501378-52-5Relevant academic research and scientific papers
SUBSTITUTED 2- AMIDOQUINAZOL-4-ONES AS MATRIX METALLOPROTEINASE-13 INHIBITORS
-
Paragraph 1637-1639; 1678-1679, (2015/12/23)
The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR1 (R1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH2), and at least one of ring B and ring C has substituent(s), provided that N-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
